The National Forensic Laboratory Information System (NFLIS) is a Drug Enforcement Administration (DEA) program that systematically collects results of forensic analyses, and other related information, from local, regional, and national entities. The program consists of three components (NFLIS-Drug, NFLIS-Tox, and NFLIS-MEC) that complement each other to provide a holistic picture of the drugs analyzed by the U.S. forensic community.

Is your laboratory interested in participating in NFLIS? If so, contact DEA at DEANFLIS@rti.org or review our FAQs document to determine your entity’s eligibility and next steps for becoming a NFLIS participant.

 Recently, DEA expanded the NFLIS program to include (1) public and private toxicology laboratory (NFLIS-Tox) data regarding postmortem and antemortem toxicological testing and (2) medical examiner and coroner office (NFLIS-MEC) data regarding deaths in which drugs were identified. These two continuous data collection programs complement NFLIS-Drug and further support the DEA’s drug regulatory and scheduling efforts. NFLIS recently reported findings from the 2017 Toxicology Laboratory Survey and 2017 Medical Examiner and Coroner Survey in support of starting the NFLIS-Tox and NFLIS-MEC programs. If your laboratory would like to participate in this endeavor, review DEA’s FAQs document to determine your entity’s eligibility to participate in NFLIS and to review other information about each NFLIS component and the next steps for participation. You may also contact DEA at DEANFLIS@rti.org.